Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor

The invention provides novel non-peptidic NPY Y2 receptor inhibitors useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss; substance...

Full description

Saved in:
Bibliographic Details
Main Authors Bonaventure, Pascal, Carruthers, Nicholas I, Chai, Wenying, Dvorak, Curt A, Jablonowski, Jill A, Rudolph, Dale A, Seierstad, Mark, Shah, Chandravadan R, Swanson, Devin M, Wong, Victoria D
Format Patent
LanguageEnglish
Published 22.05.2012
Online AccessGet full text

Cover

More Information
Summary:The invention provides novel non-peptidic NPY Y2 receptor inhibitors useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss; substance related disorders; sleep/wake disorders; cardiovascular disease; obesity; or an obesity-related disorder. Compounds of the invention are also useful in modulating endocrine functions, particularly endocrine functions controlled by the pituitary and hypothalamic glands, and are therefore useful in the treatment or prevention of inovulation and infertility. The compounds of the present invention are of the formula where Ring T is a heterocycloalkyl ring selected from the group consisting of: